Jennifer L. Lund, PhD

Jennifer Lund, PhD is associate professor of epidemiology. Dr. Lund’s research focuses at the intersection of aging, multimorbidity and oncology. She has developed expertise in health services and comparative effectiveness research. Her research aims to generate robust evidence regarding the uses, benefits and harms of medical interventions for older cancer patients.

Her geriatric oncology research addresses: 1) the quality of cancer care, 2) the effectiveness and safety of cancer treatments and 3) the role of polypharmacy, multimorbidity, and frailty in cancer treatment selection and outcomes.

Dr. Lund has worked extensively with the Surveillance, Epidemiology and End Results program (SEER) Medicare data to examine patterns of chemotherapy uptake and investigate multilevel factors associated with the dissemination of innovative treatments among older cancer patients. She also has amassed international experience using large linked databases in Canada and Denmark.

Honors and Awards

Designated a Fellow of the International Society for Pharmacoepidemiology (FISPE)

2021, International Society for Pharmacoepidemiology

Young Investigator Award Finalist

2019, International Society for Geriatric Oncology

Gordon H. DeFriese Career Development in Aging Research Award

2015, Institute on Aging, University of North Carolina at Chapel Hill

Representative Courses

EPID 766: Epidemiologic Research Using Healthcare Databases | Syllabus

Teaching Interests

This course teaches students how to use administrative healthcare utilization data for epidemiologic studies.

Research Activities

Health services research
Pharmacoepidemiology
Comparative effectiveness and safety research
Geriatric oncology research

Service Activities

Member, PhD Admissions Committee, Department of Epidemiology (2019-present)

Member, Graduate Studies Committee, Department of Epidemiology (2014-2018)

Key Publications

Life expectancy in older adults with advanced cancer: Evaluation of a geriatric assessment-based prognostic model. Lund JL, Duberstein PR, Loh KP, Gilmore N, Plumb S, Lei L, Keil AP, Islam JY, Hanson LC, Giguere JK, Vogel VG, Burnette BL, Mohile SG Journal of Geriatric Oncology (In-Press).

Effects of Anticholinergic and Sedative Medication Use on Fractures: A Self-Controlled Design Study. . Shmuel S, Pate V, Pepin MJ, Bailey JC, Golightly YM, Hanson LC, Stürmer T, Naumann RB, Gnjidic D, Lund JL.  Journal of the American Geriatrics Society (In-Press)..

Introducing Longitudinal Cumulative Dose to Describe Chemotherapy Patterns Over Time: Case Study of a Colon Cancer Trial. . Webster-Clark MA, Keil AP, Sanoff HK, Sturmer T, Westreich D, Lund JL. (1970). International Journal of Cancer, 149(2), 394-402.

Adherence to Endocrine Therapy Including Ovarian Suppression: A Large Observational Cohort Study of US Women with Early Breast Cancer. Cancer. . Reeder-Hayes KE, Mayer SE, Lund JL.  (1970). Cancer, 127(8), 1220-1227.

Risk of Cardiovascular Diseases Among Older Breast Cancer Survivors in the United States: A Matched Cohort Study. Matthews AA, Peacock Hinton S, Stanway S, Lyon AR, Smeeth L, Bhaskaran K, Lund JL (co-senior authors) (2021). Journal of National Comprehensive Cancer Network.

Effectiveness of adjuvant FOLFOX vs 5FU/LV in adults over age 65 with stage II and III colon cancer using a novel hybrid approach. Lund JL, Webster-Clark MA, Hinton SP, Shmuel S, Stürmer T, Sanoff HK. (2020). Pharmacoepidemiology and Drug Safety, 29(12), 1579-1587.

Validation of a 5-Year Mortality Prediction Model among U.S. Medicare Beneficiaries. . Ross RK, Kuo TM, Webster-Clark M, Lewis CL, Kistler CE, Jonsson Funk M, Lund JL. (2020). Journal of the American Geriatrics Society, 68(12), 2898-2902.

Education

BA, Quantitative Economics/International Relations, Tufts University, 2003

MSPH, Epidemiology, The University of North Carolina at Chapel Hill, 2009

PhD, Epidemiology, The University of North Carolina at Chapel Hill, 2011